eGuidelines.co.uk
50,196 registered users
Login | Register
 

The formulary decision guides listed below have been published with Guidelines in Practice. Click on the links to download them as Adobe Acrobat PDF files (you will need Adobe Acrobat Reader to view the PDFs: Click here to download Acrobat Reader).

Aug 2012


Warfarin sodium 1 mg/1 ml oral suspension
This formulary decision guide was developed from content provided by Rosemont Pharmaceuticals Ltd in a format developed by Guidelines in Practice. It has been reviewed by a member of the Guidelines in Practice editorial board. At all times editorial control has remained with Guidelines in Practice. (Aug 2012)

Jul 2012


Pradaxa (dabigatran etexilate) for stroke prevention in AF
This formulary decision guide was developed from content provided by Boehringer Ingelheim in a format developed by Guidelines in Practice. It has been reviewed by a member of the Guidelines in Practice editorial board. At all times editorial control has remained with Guidelines in Practice. (Jul 2012)

Jul 2012


Pimecrolimus (Elidel) 10 mg/g cream
This formulary decision guide was developed from content provided by Meda Pharmaceuticals Ltd in a format developed by Guidelines in Practice. It has been reviewed by a member of the Guidelines in Practice editorial board. At all times editorial control has remained with Guidelines in Practice. (Jul 2012)

May 2012


Qvar (HFA beclometasone dipropionate)
This formulary decision guide was developed from content provided by Teva UK Limited in a format developed by Guidelines in Practice. It has been reviewed by a member of the Guidelines in Practice editorial board. At all times editorial control has remained with Guidelines in Practice. (May 2012)

May 2012


Alendronic acid 70 mg/100 ml oral solution
This formulary decision guide was developed from content provided by Rosemont Pharmaceuticals Ltd in a format developed by Guidelines in Practice. It has been reviewed by a member of the Guidelines in Practice editorial board. At all times editorial control has remained with Guidelines in Practice. (May 2012)

Mar 2012


Ramipril 2.5 mg/5 ml oral solution
This formulary decision guide was developed from content provided by Rosemont Pharmaceuticals Ltd in a format developed by Guidelines in Practice. It has been reviewed by a member of the Guidelines in Practice editorial board. At all times editorial control has remained with Guidelines in Practice (Mar 2012)